FindTrial
Sign In

Nutritional Assessment Based on GLIM Criteria and Its Correlation with Clinical Outcomes in Hematological Tumor Patients Undergoing CAR-T Cell Therapy

Nutritional Assessment Based on GLIM Criteria and Its Correlation with Clinical Outcomes in Hematological Tumor Patients Undergoing CAR-T Cell Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115819
Enrollment
Unknown
Registered
2025-12-31
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Tumor

Interventions

Observation group:None

Sponsors

The General Hospital of Western Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. No gender restriction, aged 18-80 years; 2. Diagnosed with a hematologic tumor; 3. Planned to receive CAR-T cell therapy; 4. Suitable for body composition measurement using bioelectrical impedance analysis (BIA); 5. Agree to participate in the clinical study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Suffering from severe cardiovascular and cerebrovascular diseases, cachexia, liver and kidney diseases, gastrointestinal diseases, endocrine system diseases, infectious diseases or mental disorders; 2. Unable to continue the intervention study or whose results may be affected due to other reasons.

Design outcomes

Primary

MeasureTime frame
treatment effect;overall survival;Body composition;Nutritional assessment ;Inflammatory indicators;Serum protein level;gut microbiome;—

Countries

China

Contacts

Public ContactChao Kang

General Hospital of Western Theater Command

spiderman123007@163.com+86 28 8657 0984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026